Literature DB >> 30007919

TREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn's disease patients?

Bram Verstockt1,2, Sare Verstockt3, Helene Blevi2, Isabelle Cleynen3, Magali de Bruyn2, Gert Van Assche1,2, Séverine Vermeire1,2, Marc Ferrante1,2.   

Abstract

Entities:  

Keywords:  crohn’s disease; ibd clinical; infliximab; tnf-alpha

Mesh：

Substances：

Year:  2018        PMID： 30007919     DOI： 10.1136/gutjnl-2018-316845

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  22 in total

Review 1.  The Future of Precision Medicine to Predict Outcomes and Control Tissue Remodeling in Inflammatory Bowel Disease.

Authors:  Christopher A Lamb; Aamir Saifuddin; Nick Powell; Florian Rieder
Journal:  Gastroenterology       Date:  2022-01-04       Impact factor: 22.682

2.  Development of a Machine Learning Model to Predict Non-Durable Response to Anti-TNF Therapy in Crohn's Disease Using Transcriptome Imputed from Genotypes.

Authors:  Soo Kyung Park; Yea Bean Kim; Sangsoo Kim; Chil Woo Lee; Chang Hwan Choi; Sang-Bum Kang; Tae Oh Kim; Ki Bae Bang; Jaeyoung Chun; Jae Myung Cha; Jong Pil Im; Min Suk Kim; Kwang Sung Ahn; Seon-Young Kim; Dong Il Park
Journal:  J Pers Med       Date:  2022-06-09

3.  Biomarkers of Crohn's Disease to Support the Development of New Therapeutic Interventions.

Authors:  Amy C Porter; Jiri Aubrecht; Chandler Birch; Jonathan Braun; Carolyn Cuff; Suryasarathi Dasgupta; Jeremy D Gale; Robert Hinton; Steven C Hoffmann; Gerard Honig; Bryan Linggi; Marco Schito; Niels Vande Casteele; John-Michael Sauer
Journal:  Inflamm Bowel Dis       Date:  2020-09-18       Impact factor: 5.325

4.  Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease.

Authors:  Sare Verstockt; Bram Verstockt; Kathleen Machiels; Maaike Vancamelbeke; Marc Ferrante; Isabelle Cleynen; Gert De Hertogh; Séverine Vermeire
Journal:  Inflamm Bowel Dis       Date:  2021-10-18       Impact factor: 5.325

Review 5.  Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Disease Outcome and Response to Therapy.

Authors:  Bram Verstockt; Nurulamin M Noor; Urko M Marigorta; Polychronis Pavlidis; Parakkal Deepak; Ryan C Ungaro
Journal:  J Crohns Colitis       Date:  2021-09-25       Impact factor: 9.071

6.  A Series of Genes for Predicting Responses to Anti-Tumor Necrosis Factor α Therapy in Crohn's Disease.

Authors:  Kai Nie; Chao Zhang; Minzi Deng; Weiwei Luo; Kejia Ma; Jiahao Xu; Xing Wu; Yuanyuan Yang; Xiaoyan Wang
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

7.  Pre-Treatment Biomarkers of Anti-Tumour Necrosis Factor Therapy Response in Crohn's Disease-A Systematic Review and Gene Ontology Analysis.

Authors:  Boris Gole; Uroš Potočnik
Journal:  Cells       Date:  2019-05-28       Impact factor: 6.600

Review 8.  One Size Does Not Fit All: The Case for Translational Medicine.

Authors:  Yehuda Chowers
Journal:  Rambam Maimonides Med J       Date:  2019-04-18

Review 9.  Molecular Profiling of Inflammatory Bowel Disease: Is It Ready for Use in Clinical Decision-Making?

Authors:  Ho-Su Lee; Isabelle Cleynen
Journal:  Cells       Date:  2019-06-04       Impact factor: 6.600

10.  Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease.

Authors:  Bram Verstockt; Sare Verstockt; Jonas Dehairs; Vera Ballet; Helene Blevi; Willem-Jan Wollants; Christine Breynaert; Gert Van Assche; Séverine Vermeire; Marc Ferrante
Journal:  EBioMedicine       Date:  2019-01-24       Impact factor: 8.143
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.